Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis

Abstract

The p53 tumor suppressor protein, a transcription factor, induces cell cycle arrest and apoptosis via the upregulation of downstream target genes. Ferredoxin Reductase (protein, FR; gene, FDXR) transfers electron from NADPH to cytochrome P450 via ferredoxin in mitochondria. Here, we identified FDXR as a target gene of the p53 family, that is, p53, p63, and p73. We found that FDXR can be induced by DNA damage in cells in a p53-dependent manner and by a mutated form of p53 that is competent in inducing apoptosis. In addition, we identified a p53 response element located within the FDXR promoter that is responsive to wild-type p53, p63α, p63γ, p73α, and p73β. Furthermore, we showed that p53, p63α and p73α directly bind to the p53 response element in vivo and promote the accessibility of the FDXR promoter by increasing the acetylation of histones H3 and H4. To determine the role of FR in p53 tumor suppression, we generated cell lines that express FR using a tetracycline-regulated promoter. We found that over-expression of FR in lung H1299, breast MCF7, and colorectal HCT116 carcinoma cells have no effect on cell proliferation. However, we showed that FR increases the sensibility of H1299 and HCT116 cells to 5-fluorouracil-, doxorubicin- and H2O2- mediated apoptosis. Our data support a model of feed-forward loop for p53 activity, that is, various cellular stresses, including reactive oxygen species (ROS), activate p53, which induces the expression of FDXR; and the FDXR gene product, FR, in turn sensitizes cells to ROS-mediated apoptosis.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Akman SA, Doroshow JH, Burke TG, Dizdaroglu M . 1992 Biochemistry 31: 3500–3506

  • Allen RG, Tresini M . 2000 Free Radic. Biol. Med. 28: 463–499

  • Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B . 1998 Science 282: 1497–1501

  • Chandra J, Samali A, Orrenius S . 2000 Free Radic. Biol. Med. 29: 323–333

  • Chen H, Lin RJ, Xie W, Wilpitz D, Evans RM . 1999 Cell 98: 675–686

  • Chen J, Willingham T, Shuford M, Bruce D, Rushing E, Smith Y, Nisen PD . 1996a Oncogene 13: 1395–1403

  • Chen X . 1999 Mol. Med. Today 5: 387–392

  • Chen X, Bargonetti J, Prives C . 1995 Cancer Res. 55: 4257–4263

  • Chen X, Ko LJ, Jayaraman L, Prives C . 1996b Genes Dev. 10: 2438–2451

  • Dohn M, Jiang J, Chen X . 2001a Oncogene 20: 6503–6515

  • Dohn M, Zhang S, Chen X . 2001b Oncogene 20: 3193–3205

  • el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B . 1993 Cell 75: 817–825

  • Hanukoglu I, Gutfinger T . 1989 Eur. J. Biochem. 180: 479–484

  • Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ . 1993 Cell 75: 805–816

  • Hermeking H, Lengauer C, Polyak K, He T-C, Zhang L, Thiagalingam S, Kinzler KW, Vogelstein B . 1997 Mol. Cell 1: 3–11

  • Hollstein M, Sidransky D, Vogelstein B, Harris CC . 1991 Science 253: 49–53

  • Hwang PM, Bunz F, Yu J, Rago C, Chan TA, Murphy MP, Kelso GF, Smith RA, Kinzler KW, Vogelstein B . 2001 Nat. Med. 7: 1111–1117

  • Irwin MS, Kaelin WG . 2001 Cell Growth Differ. 12: 337–349

  • Kaelin Jr WG . 1999 J. Natl. Cancer Inst. 91: 594–598

  • Ko LJ, Prives C . 1996 Genes Dev. 10: 1054–1072

  • Kramer RE, Du Bois RN, Simpson ER, Anderson CM, Kashiwagi K, Lambeth JD, Jefcoate CR, Waterman MR . 1982 Arch. Biochem. Biophys. 215: 478–485

  • Miyashita T, Reed JC . 1995 Cell 80: 293–299

  • Muller JJ, Lapko A, Bourenkov G, Ruckpaul K, Heinemann U . 2001 J. Biol. Chem. 276: 2786–2789

  • Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R . 1989 J. Virol. 63: 4417–4421

  • Nakano K, Vousden KH . 2001 Mol. Cell 7: 683–694

  • Nelson WG, Kastan MB . 1994 Mol. Cell. Biol. 14: 1815–1823

  • Szak ST, Mays D, Pietenpol JA . 2001 Mol. Cell. Biol. 21: 3375–3386

  • Urnov FD, Wolffe AP . 2001 Oncogene 20: 2991–3006

  • Vogelstein B, Lane D, Levine AJ . 2000 Nature 408: 307–310

  • Waldman T, Kinzler KW, Vogelstein B . 1995 Cancer Res. 55: 5187–5190

  • Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace Jr AJ, Harris CC . 1999 Proc. Natl. Acad. Sci. USA 96: 3706–3711

  • Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D . 1993 Nature 366: 701–704

  • Yang A, Kaghad M, Caput D, McKeon F . 2002 Trends Genet 18: 90–95

  • Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F . 1998 Mol. Cell. 2: 305–316

  • Yang A, McKeon F . 2000 Nat. Rev. Mol. Cell. Biol. 1: 199–207

  • Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B . 2001 Mol. Cell. 7: 673–682

  • Zhu J, Chen X . 2000 Mol. Cell. Biol. 20: 5602–5618

  • Zhu J, Jiang J, Zhou W, Chen X . 1998a Cancer Res. 58: 5061–5065

  • Zhu J, Jiang J, Zhou W, Zhu K, Chen X . 1999 Oncogene 18: 2149–2155

  • Zhu J, Zhang S, Jiang J, Chen X . 2000 J. Biol. Chem. 275: 39927–39934

  • Zhu J, Zhou W, Jiang J, Chen X . 1998b J. Biol. Chem. 273: 13030–13036

Download references

Acknowledgements

We would like to thank Jianhui Zhu for technical help and Terry Stroming (Medical College of Georgia) for Affymetrix GeneChip assay. We are grateful to Dr Bert Vogelstein for providing several HCT116 cell lines and anti-FR antibody and Dr Qiman Zhan for providing HCT116 tet-off inducible cell line. This work is supported in part by NCI grant RO1 CA81237 and CA76069.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xinbin Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, G., Chen, X. The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis. Oncogene 21, 7195–7204 (2002). https://doi.org/10.1038/sj.onc.1205862

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205862

Keywords

This article is cited by

Search

Quick links